Go to the list of all blogs
Allana's Avatar
published in Blogs
Jul 25, 2026
Oracle Corporation (ORCL) Shares Drop 24.6% as AI Capex Concerns Intensify

Oracle Corporation (ORCL) Shares Drop 24.6% as AI Capex Concerns Intensify

Key Takeaways

  • Oracle shares have fallen 24.6% over the past 30 days, plunging from $152.46 on June 25 to $114.99 on July 24, hitting fresh 52-week lows.
  • The sell-off accelerated after S&P Global Ratings downgraded Oracle's credit rating to BBB- on July 9, one notch above junk status, citing unsustainable AI infrastructure spending.
  • Fiscal 2026 free cash flow reached negative $23.7 billion as capital expenditures swelled to $55.7 billion, and management guided for up to $95 billion in fiscal 2027 capex.
  • Despite the stock's collapse, Oracle's underlying business remains strong: fiscal 2026 revenue rose 17% to $67.4 billion, and remaining performance obligations hit a record $638 billion.
  • Wall Street analysts remain largely bullish, with an average price target near $248 — more than double the current share price — though concentration risk tied to OpenAI commitments remains a key concern.

Oracle Corporation (ORCL) Company Overview and Market Position

Oracle Corporation is one of the world's largest enterprise technology companies, best known for its database management systems, enterprise resource planning software, and rapidly expanding cloud infrastructure business. Founded in 1977 and headquartered in Austin, Texas, Oracle has spent the last several years pivoting from its legacy on-premise software model toward cloud-based services, competing directly with hyperscale cloud providers including AMZN, MSFT, and GOOGL. The company's Oracle Cloud Infrastructure (OCI) segment has become a central player in the artificial intelligence infrastructure race, securing multi-billion-dollar contracts with AI developers including OpenAI. Oracle's competitive advantage rests on its entrenched enterprise customer relationships, high-performance database technology, and a multi-cloud strategy that increasingly positions OCI as an AI-training and inference alternative to the Big Three cloud vendors. Investors track ORCL closely as both a legacy software bellwether and an emerging AI infrastructure contender. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Oracle Corporation (ORCL) Stock Price Performance: Last 30 Days vs. Quarter

Over the last 30 calendar days, Oracle shares have tumbled 24.6%, declining from a closing price of $152.46 on June 25, 2026, to $114.99 at the close on July 24. The stock touched a fresh 52-week low of $114.75 during the final session of the period, marking its lowest level in more than two years. Trading volumes have consistently run above the 90-day average, indicating elevated institutional selling pressure rather than routine drift.

Zooming out to a quarterly view, the decline is even more dramatic. Oracle traded near $173 at the end of April and surged to an intra-quarter peak of $248.15 on June 1 following strong fiscal fourth-quarter results. From that peak, the stock has shed approximately 54% of its value — an extraordinary reversal within a single quarter. The broader multi-month trend reflects a market-wide reassessment of AI infrastructure spending, with Oracle at the epicenter due to its aggressive capital expenditure commitments relative to its balance sheet capacity. From what I see, this kind of sharp reversal often signals deeper shifts in how the market values growth versus risk.

What Drove ORCL Stock Price in the Last 30 Days

The sharp 30-day decline has been fueled by a cascade of negative developments centered on Oracle's balance sheet and the scale of its AI-related spending. On July 9, S&P Global Ratings downgraded Oracle's long-term credit rating from BBB to BBB-, leaving the company just one notch above speculative-grade territory. S&P explicitly cited the enormous cost of Oracle's AI data center build-out, projecting fiscal 2027 capital expenditures of $90 billion to $95 billion and a free operating cash flow deficit widening to approximately $42 billion. Oracle's five-year credit default swap spreads subsequently surged to their highest levels in nearly 18 years.

Compounding the credit concerns, a New Mexico regulator again rejected a pipeline permit critical to powering Oracle's flagship Project Jupiter data center, threatening construction timelines. Separately, reports of a potential Clop ransomware group intrusion surfaced in mid-July, raising cybersecurity and reputational risks. Additionally, Oracle confirmed plans to raise approximately $40 billion through debt and equity financing in fiscal 2027, including a $20 billion share issuance that will dilute existing shareholders. These developments landed on a stock already reeling from broader AI capex anxiety, as investors across the sector began questioning whether enormous infrastructure investments will generate adequate returns. I also checked this using Tickeron’s AI Pattern Search Engine to review similar historical setups.

What Drove ORCL Stock Performance Over the Last Quarter

Oracle's quarterly journey tells a story of dramatic reversal. The stock initially surged in late May and early June after the company reported fiscal fourth-quarter results that exceeded expectations: revenue of $19.2 billion, up 21% year over year, with cloud infrastructure revenue soaring 93% to $5.8 billion. Remaining performance obligations reached $638 billion — up an extraordinary 363% from the prior year. The market briefly priced Oracle as a premier AI winner, pushing shares near $250.

That narrative cracked almost immediately once investors absorbed the full cost picture. The same earnings release revealed that fiscal 2026 capital expenditures had consumed all of the company's record $32 billion in operating cash flow, producing negative free cash flow of $23.7 billion. With management guiding for even higher spending in fiscal 2027 and S&P's subsequent downgrade validating balance-sheet fears, the market rapidly repriced Oracle from an AI growth story to a credit-risk story. The stock's 54% decline from its quarterly peak reflects a profound shift in sentiment: revenue growth and backlog metrics that once commanded premium multiples are now being viewed through the lens of debt sustainability and dilution risk.

ORCL Stock Forecast Drivers: What Investors Should Watch Next

Several factors will determine Oracle's trajectory from here. First, the company's planned $20 billion equity issuance — and the terms at which it prices — will be a critical test of institutional demand and could set a near-term floor or ceiling for the stock. Second, quarterly updates on remaining performance obligation conversion rates will reveal whether the $638 billion backlog is translating into revenue on schedule, particularly the portion tied to OpenAI. Third, any additional rating agency actions from Moody's, which already maintains a negative outlook on Oracle, could pressure borrowing costs further.

On the operational side, resolution of the New Mexico pipeline dispute for Project Jupiter and progress on the Stargate data center in Texas will serve as bellwethers for execution capability. Broader macro developments — including interest rate policy, AI enterprise adoption trends, and competitive dynamics among hyperscale cloud providers — will also shape sentiment. With Oracle trading at roughly 14 to 16 times forward adjusted earnings, the stock's valuation now embeds significant skepticism; the gap between the current price and the average analyst target of approximately $248 underscores the importance of upcoming quarterly data in resolving whether the market's fears or the backlog's promise proves more accurate. I'm watching this closely as the next earnings release could clarify the path forward.

Exploring AI-Powered Trading Approaches

In volatile environments like the one ORCL is navigating, I find it useful to look at systematic strategies alongside fundamental analysis. Tickeron’s Trending AI Robots page highlights top-performing AI-driven trading bots across various timeframes and risk profiles. It offers a practical way to review performance metrics and methodologies that complement traditional research when markets shift quickly.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ORCL

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


ORCL in upward trend: price rose above 50-day moving average on August 21, 2026

ORCL moved above its 50-day moving average on August 21, 2026 date and that indicates a change from a downward trend to an upward trend. In of 32 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ORCL's RSI Oscillator exited the oversold zone, of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 57 cases where ORCL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ORCL just turned positive on July 22, 2026. Looking at past instances where ORCL's MACD turned positive, the stock continued to rise in of 37 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for ORCL crossed bullishly above the 50-day moving average on August 19, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ORCL advanced for three days, in of 334 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ORCL as a result. In of 69 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ORCL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ORCL broke above its upper Bollinger Band on August 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ORCL entered a downward trend on August 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.236) is normal, around the industry mean (22.706). P/E Ratio (25.123) is within average values for comparable stocks, (70.701). Projected Growth (PEG Ratio) (0.828) is also within normal values, averaging (2.165). Dividend Yield (0.014) settles around the average of (0.021) among similar stocks. P/S Ratio (6.337) is also within normal values, averaging (111.934).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ORCL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ORCL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are Microsoft Corp (NASDAQ:MSFT), Oracle Corp (NYSE:ORCL), Palo Alto Networks Inc (NASDAQ:PANW), Crowdstrike Holdings Inc (NASDAQ:CRWD), Block Inc (NYSE:XYZ), NetApp (NASDAQ:NTAP), MongoDB (NASDAQ:MDB), Twilio (NYSE:TWLO), Zscaler (NASDAQ:ZS), Okta (NASDAQ:OKTA).

Industry description

Computer communications industry develops technology that allows computing devices to exchange data with each other using connections/data links between nodes. Common types of computer network include Cloud (IAN), Internet, Wide (WAN, Local (LAN)/Wireless(WLAN) etc. The industry is an ever-more important part of technology, and is set to become even bigger as the Internet of Things (IoT) rapidly forays into the various aspects of our lives. Cisco Systems, Inc., Palo Alto Networks, Inc. and Arista Networks, Inc., Fortinet, Inc. are some of the major computer communications companies.

Market Cap

The average market capitalization across the Computer Communications Industry is 33.88B. The market cap for tickers in the group ranges from 48.8K to 3.59T. MSFT holds the highest valuation in this group at 3.59T. The lowest valued company is WMHI at 48.8K.

High and low price notable news

The average weekly price growth across all stocks in the Computer Communications Industry was -2%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was 19%. WETO experienced the highest price growth at 216%, while YYAI experienced the biggest fall at -95%.

Volume

The average weekly volume growth across all stocks in the Computer Communications Industry was -2%. For the same stocks of the Industry, the average monthly volume growth was -11% and the average quarterly volume growth was -60%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 71
Price Growth Rating: 55
SMR Rating: 79
Profit Risk Rating: 91
Seasonality Score: -7 (-100 ... +100)
View a ticker or compare two or three
ORCL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of a diversified line of business software products

Industry ComputerCommunications

Profile
Details
Industry
Packaged Software
Address
2300 Oracle Way
Phone
+1 737 867-1000
Employees
164000
Web
https://www.oracle.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.